Literature DB >> 19640636

Sellar neuroblastoma mimicking a pituitary tumour: case report and review of the literature.

K Schmalisch1, T Psaras, R Beschorner, J Honegger.   

Abstract

Neuroblastomas of the sellar region are exceedingly rare. Only 2 cases have previously been reported. Management of these tumours depends on the tumour's primary site, the patient's age and histopathological features. We are reporting the case of a 43-year-old woman who developed progressive bitemporal hemianopsia and visual loss, accompanied by amenorrhea and hyponatremia. Laboratory findings revealed a slightly elevated prolactin level. Cranial MR-imaging displayed an intrasellar and suprasellar lesion with a maximum diameter of 2.5 cm that was suspicious for a pituitary adenoma or tuberculum sellae meningioma. The tumour was approached via a pterional trepanation. Intraoperatively, the tumour was highly vascularized and adhesive to the optic chiasm, the floor of the third ventricle, the hypothalamus and the hypophyseal stalk. Postoperatively, vision improved and prolactin dropped to normal values, but hyponatremia persisted. Histopathological examination revealed a neuroblastoma with strong positivity for synaptophysin and chromogranin, MAP-2 protein and NeuN-antigen in the immunohistochemistry. No pituitary hormone receptors were expressed. The MIB-1 labelling index was positive in 5% of the cell nucleoli. In the further course, the patient underwent radiotherapy of the neuroaxis. A brief review of the literature is presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640636     DOI: 10.1016/j.clineuro.2009.06.011

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Primary sellar neuroblastoma presenting with syndrome of inappropriate secretion of anti-diuretic hormone.

Authors:  Bishan Radotra; Vasileios Apostolopoulos; Ann Sandison; Emma C I Hatfield; Nigel Mendoza; Jill Moss; Amrish Mehta; Mark Glaser; Karim Meeran; Federico Roncaroli
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

2.  Sellar Chordoma Presenting as Pseudo-macroprolactinoma with Unilateral Third Cranial Nerve Palsy.

Authors:  Hai-Feng Wang; Hong-Xi Ma; Cheng-Yuan Ma; Yi-Nan Luo; Peng-Fei Ge
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

Review 3.  Paraneoplastic syndromes in olfactory neuroblastoma.

Authors:  Michał Kunc; Anna Gabrych; Piotr Czapiewski; Krzysztof Sworczak
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26

4.  Primary Sellar Neuroblastoma in an Elderly Patient: Case Report.

Authors:  Shun Yamamuro; Takao Fukushima; Atsuo Yoshino; Kazunari Yachi; Akiyoshi Ogino; Yoichi Katayama
Journal:  NMC Case Rep J       Date:  2014-12-15

5.  A sellar neuroblastoma showing rapid growth and causing syndrome of inappropriate secretion of antidiuretic hormone: A case report.

Authors:  Muhammad Kamil; Nayuta Higa; Hajime Yonezawa; Shingo Fujio; Jun Sugata; Tomoko Takajo; Tsubasa Hiraki; Junko Hirato; Kazunori Arita; Koji Yoshimoto
Journal:  Surg Neurol Int       Date:  2020-06-27

6.  LGR5 and Downstream Intracellular Signaling Proteins Play Critical Roles in the Cell Proliferation of Neuroblastoma, Meningioma and Pituitary Adenoma.

Authors:  Mina Hwang; Myung-Hoon Han; Hyun-Hee Park; Hojin Choi; Kyu-Yong Lee; Young Joo Lee; Jae Min Kim; Jin Hwan Cheong; Je Il Ryu; Kyueng-Whan Min; Young-Ha Oh; Yong Ko; Seong-Ho Koh
Journal:  Exp Neurobiol       Date:  2019-10-31       Impact factor: 3.261

7.  Synchronous esthesioneuroblastoma and growth-hormone-secreting pituitary macroadenoma: combined open and endoscopic management.

Authors:  Costanza J Valdes; Marc A Tewfik; Marie-Christine Guiot; Salvatore Di Maio
Journal:  J Neurol Surg Rep       Date:  2014-07-21

8.  Sellar Embryonal Tumor: A Case Report and Review of the Literature.

Authors:  Fatih Yakar; İhsan Doğan; Cem Meco; Aylin Okcu Heper; Gokmen Kahilogullari
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.